Journal Mobile Options
Table of Contents
Vol. 115, No. 3-4, 2006
Issue release date: March 2006
Acta Haematol 2006;115:221–229

Exercise-Induced Deep Vein Thrombosis of the Upper Extremity

2. A Case Series in Children

Brandão L.R. · Williams S. · Kahr W.H.A.. · Ryan C. · Temple M. · Chan A.K.C.
aDivision of Haematology/Oncology, Department of Paediatrics, bDepartment of Diagnostic Imaging, Centre for Image Guided Therapy and cDepartment of Paediatric Laboratory Medicine, The Hospital for Sick Children, Toronto; dDepartment of Paediatrics, McMaster University, Hamilton, Canada

Individual Users: Register with Karger Login Information

Please create your User ID & Password

Contact Information

I have read the Karger Terms and Conditions and agree.

To view the fulltext, please log in

To view the pdf, please log in


Upper-extremity deep venous thrombosis (UEDVT) is an increasingly important clinical problem in children. These events are classified as primary or secondary, with the latter being the most common and usually associated with the presence of a central venous line. Among primary UEDVT, the so-called Paget-Schroetter syndrome, effort-related or exercise-induced upper-extremity thrombotic event represents an extremely rare finding that has never been described in a pediatric series. The objective of the second part of this two-part article is to report the first pediatric series in a group of adolescents with this condition from a single center, describing their clinical features, management, and outcome. A retrospective chart review of 6 patients seen between December 2003 and April 2005 was conducted, with a median follow-up of 9 months (range 2–17). Four females and two males, all Caucasian, were enrolled with a median age of 16 years (range 14–17). In all cases, strenuous exercise was present in the month preceding diagnosis and mild trauma was present in only one case (weight lifting). At presentation, all patients had objective swelling of the affected limb for a median of 4 days (range 2–14), and 4 patients had UEDVT of the dominant arm. Thrombophilia investigation revealed that 50% had a combined prothrombotic state at presentation, and all patients were/are being treated with anticoagulation for 6 months (low-molecular-weight heparin followed by warfarin). Continuation of the initial symptoms was present in all cases but one at the 3-month clinic follow-up (last case has yet to reach 3 months of follow-up), and residual moderate to severe postthrombotic syndrome was present in all 3 cases followed for more than 12 months. Of those 3 patients followed for more than 1 year, 2 patients recurred despite having complete resolution of the thrombus after 6 months of anticoagulation, and the third patient underwent surgery with clinical improvement. Adolescents with UEDVT treated only with anticoagulation seem to have a poor outcome.

Copyright / Drug Dosage

Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher or, in the case of photocopying, direct payment of a specified fee to the Copyright Clearance Center.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in goverment regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.


  1. Brandão LR, Williams S, Kahr WHA, Ryan C, Temple M, Chan AKC: Exercise-induced deep vein thrombosis of the upper extremity. 1. Literature review. Acta Haematol 2006;115:214–220.

    External Resources

  2. Baxter BT, Blackburn D, Payne K, Pearce WH, Yao JS: Noninvasive evaluation of the upper extremity. Surg Clin North Am 1990;70/1:87–97.

    External Resources

  3. Goodnight SH Jr, Hathaway W: Disorders of Hemostasis and Thrombosis – A Clinical Guide. New York, McGraw-Hill, 2001.
  4. Andrew M, Monagle P, Brooker L: Thromboembolic Complications during Infancy and Childhood. Hamilton, BC Decker, 2000.
  5. deVeber G, Monagle P, Chan A, MacGregor D, Curtis R, Lee S, Vegh P, Adams M, Marzinotto V, Leaker M, Massicotte MP, Lillicrap D, Andrew M: Prothrombotic disorders in infants and children with cerebral thromboembolism. Arch Neurol 1998;55:1539–1543.
  6. Kuhle S, Koloshuk B, Marzinotto V, Bauman M, Massicotte P, Andrew M, Chan A, Abdolell M, Mitchell L: A cross-sectional study evaluating post-thrombotic syndrome in children. Thromb Res 2003;111/4–5:227–233.
  7. Villalta S, Bagatella P, Piccioli A: Assessment of validity and reproducibility of a clinical scale for the post-thrombotic syndrome (abstract). Haemostasis 1994;24:158a.
  8. Monagle P, Chan A, Massicotte P, Chalmers E, Michelson AD: Antithrombotic therapy in children: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest 2004;126(3 suppl):645S–687S.

    External Resources

  9. Harley DP, White RA, Nelson RJ, Mehringer CM: Pulmonary embolism secondary to venous thrombosis of the arm. Am J Surg 1984;147/2:221–224.
  10. Heron E, Lozinguez O, Alhenc-Gelas M, Emmerich J, Fiessinger JN: Hypercoagulable states in primary upper-extremity deep vein thrombosis. Arch Intern Med 2000;160:382–386.
  11. Martinelli I, Battaglioli T, Bucciarelli P, Passamonti SM, Mannucci PM: Risk factors and recurrence rate of primary deep vein thrombosis of the upper extremities. Circulation 2004;110:566–570.
  12. Hendler MF, Meschengieser SS, Blanco AN, Alberto MF, Salviu MJ, Gennari L, Lazzari MA: Primary upper-extremity deep vein thrombosis: high prevalence of thrombophilic defects. Am J Hematol 2004;76:330–337.
  13. Andrew M, Mitchell L, Vegh P, Ofosu F: Thrombin regulation in children differs from adults in the absence and presence of heparin. Thromb Haemost 1994;72:836–842.
  14. Siegbahn A, Ruusuvaara L: Age dependence of blood fibrinolytic components and the effects of low-dose oral contraceptives on coagulation and fibrinolysis in teenagers. Thromb Haemost 1988;60:361–364.
  15. Killewich LA, Macko RF, Montgomery PS, Wiley LA, Gardner AW: Exercise training enhances endogenous fibrinolysis in peripheral arterial disease. J Vasc Surg 2004;40:741–745.
  16. Hughes ES: Venous obstruction in upper extremity (Paget-Schroetter’s syndrome). Review of 320 cases. Int Abstr Surg 1949;88:89–127.
  17. Tilney ML, Griffiths HJ, Edwards EA: Natural history of major venous thrombosis of the upper extremity. Arch Surg 1970;101:792–796.
  18. Kahn SR, Elman EA, Bornais C, Blostein M, Wells PS: Post-thrombotic syndrome, functional disability and quality of life after upper extremity deep venous thrombosis in adults. Thromb Haemost 2005;93:499–502.
  19. Arko FR, Harris EJ, Zarins CK, Olcott C: Vascular complications in high-performance athletes. J Vasc Surg 2001;33:935–942.
  20. Sabeti S, Schillinger M, Mlekusch W, Haumer M, Ahmadi R, Minar E: Treatment of subclavian-axillary vein thrombosis: long-term outcome of anticoagulation versus systemic thrombolysis. Thromb Res 2002;108/5–6:279–285.
  21. Rutherford RB, Hurlbert SN: Primary subclavian-axillary vein thrombosis: consensus and commentary. Cardiovasc Surg 1996;4:420–423.
  22. Khan SN, Stansby G: Current management of Paget-Schroetter syndrome in the UK. Ann R Coll Surg Engl 2004;86/1:29–34.
  23. Andrew M, David M, Adams M, Ali K, Anderson R, Barnard D, Bernstein M, Brisson L, Cairney B, DeSai D: Venous thromboembolic complications (VTE) in children: first analyses of the Canadian Registry of VTE. Blood 1994;83:1251–1257.
  24. Gorenstein A, Katz S, Levy P, Schiller M: Non-iatrogenic deep vein thrombosis of lower extremities in children. Z Kinderchir 1986;41:375–378.
  25. Massicotte MP, Dix D, Monagle P, Adams M, Andrew M: Central venous catheter related thrombosis in children: analysis of the Canadian Registry of Venous Thromboembolic Complications. J Pediatr 1998;133:770–776.
  26. Monagle P, Adams M, Mahoney M, Ali K, Barnard D, Bernstein M, Brisson L, David M, Desai S, Scully MF, Halton J, Israels S, Jardine L, Leaker M, McCusker P, Silva M, Wu J, Anderson R, Andrew M, Massicotte MP: Outcome of pediatric thromboembolic disease: a report from the Canadian Childhood Thrombophilia Registry. Pediatr Res 2000;47:763–766.
  27. Hausler M, Hubner D, Delhaas T, Muhler EG: Long term complications of inferior vena cava thrombosis. Arch Dis Child 2001;85/3:228–233.
  28. Gurgey A, Aslan D: Outcome of noncatheter-related thrombosis in children: influence of underlying or coexisting factors. J Pediatr Hematol Oncol 2001;23/3:159–164.
  29. Marzinotto V, Choi M, Massicotte MP: Post-thrombotic syndrome in children with previous deep vein thrombosis (abstract). Thromb Haemost 2001;78(suppl):OC962.
  30. van Ommen CH, Ottenkamp J, Lam J, Brennickmeier M, Heijmans HS, Buller HR, Peters M: The risk of postthrombotic syndrome in children with congenital heart disease. J Pediatr 2002;141:582–586.
  31. Goldenberg NA, Knapp-Clevenger R, Manco-Johnson MJ: Elevated plasma factor VIII and D-dimer levels as predictors of poor outcomes of thrombosis in children. N Engl J Med 2004;351:1081–1088.
  32. Revel-Vilk S, Sharathkumar A, Massicotte P, Marzinotto V, Daneman A, Dix D, Chan A: Natural history of arterial and venous thrombosis in children treated with low molecular weight heparin: a longitudinal study by ultrasound. J Thromb Haemost 2004;2/1:42–46.
  33. Prandoni P, Villalta S, Bagatella P, Rossi L, Marchiori A, Piccioli A, Bernardi E, Girolami B, Simioni P, Girolami A: The clinical course of deep-vein thrombosis. Prospective long-term follow-up of 528 symptomatic patients. Haematologica 1997;82:423–428.
  34. Ageno W, Piantanida E, Dentali F, Steidl L, Mera V, Squizzato A, Marchesi C, Venco A: Body mass index is associated with the development of the post-thrombotic syndrome. Thromb Haemost 2003;89:305–309.

Pay-per-View Options
Direct payment This item at the regular price: USD 38.00
Payment from account With a Karger Pay-per-View account (down payment USD 150) you profit from a special rate for this and other single items.
This item at the discounted price: USD 26.50